Clinical Trial Results Look Good for Possible Treatment for Transfusion Dependent Beta Thalassemia
According to a story from Market Screener, the biopharmaceutical company Orchard Therapeutics recently announced that the results of a recent clinical trial testing the company' investigational product OTL-300 were encouraging.…